Geneva Capital Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.13M | Sell |
|
|||||
|
2025
Q1 | $1.08M | Sell |
|
|||||
|
2024
Q4 | $1.13M | Sell |
|
|||||
|
2024
Q3 | $1.08M | Sell |
|
|||||
|
2024
Q2 | $1.64M | Sell |
|
|||||
|
2024
Q1 | $2.12M | Sell |
|
|||||
|
2023
Q4 | $1.77M | Sell |
|
|||||
|
2023
Q3 | $1.69M | Sell |
|
|||||
|
2023
Q2 | $3.19M | Sell |
|
|||||
|
2023
Q1 | $2.91M | Sell |
|
|||||
|
2022
Q4 | $2.82M | Buy |
|
|||||
|
2022
Q3 | $3.02M | Sell |
|
|||||
|
2022
Q2 | $3.48M | Sell |
|
|||||
|
2022
Q1 | $4.35M | Buy |
|
|||||
|
2021
Q4 | $4.74M | Sell |
|
|||||
|
2021
Q3 | $4.24M | Sell |
|
|||||
|
2021
Q2 | $3.99M | Sell |
|
|||||
|
2021
Q1 | $3.24M | Buy |
|
|||||
|
2020
Q4 | $3.12M | Buy |
|
|||||
|
2020
Q3 | $2.73M | Buy |
|
|||||
|
2020
Q2 | $2.34M | Buy |
|
|||||
|
2020
Q1 | $2.11M | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $35.5M | Sell |
|
|||||
|
2013
Q2 | $49.1M | Buy |
|